Alderm N.A. Announces FDA Clearance for the Med Sculpt™ Cellulite Reduction System

Share Article

“The Ultimate in Body Sculpting” system is the latest technology for the treatment of cellulite is approved for use in the United States and is exclusively distributed by Alderm N.A., LLC.

Alderm, N.A. LLC, announced that it has received FDA clearance to market the Med Sculpt™ Computerized Body Massage and M-Sonic Ultrasound Diathermy system for the treatment and reduction of cellulite. Med Sculpt is a revolutionary system for non-invasive cellulite treatment. Patients have no downtime and can return to their normal activities while completing the treatment. With thousands of successful treatments in Europe over the last three years, Alderm N.A. is excited to make this technology available in the United States.

Dr. Rose Paiva of Reno, NV, who is one of the first physicians in the country to start using the Med Sculpt commented, “After studying the clinical results from the European studies on the Med Sculpt I am certain that my patients are going to see absolutely fabulous results from the Med Sculpt. The Med Sculpt is just one of the most unique treatment systems for treating cellulite that I have seen. I'm excited about the Med Sculpt and so are my patients.”

Med Sculpt represents the latest advancement in computerized, non-invasive, cellulite reduction technology. It uses a powerful computerized vacuum massage to stimulate circulation and reduce cellulite. It is also has an ultrasound hand piece that provides additional treatment modalities. “Patients will see dramatic results after just a few treatment sessions. And, treatment sessions are just 20 minutes with absolutely no down time. A patient could literally come in for a lunch time treatment and be back to work right away,” said James Kraushaar, CEO of Alderm N.A. “The Med Sculpt is unique among cellulite treatment systems in that it is quick, efficacious and painless.”

To learn more about Med Sculpt™ visit, email, or call (800) 254-8505.


Share article on social media or email:

View article via:

Pdf Print

Contact Author

Jim Kraushaar
Visit website